Join

Compare · HCXY vs IBB

HCXY vs IBB

Side-by-side comparison of Hercules Capital, Inc. (HCXY) and iShares Nasdaq Biotechnology Index Fund (IBB): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both HCXY and IBB operate in n/a (n/a), so they compete in similar markets.
  • HCXY carries a market cap of $4.53B.
  • Over the past year, HCXY is down 0.5% and IBB is up 30.7% - IBB leads by 31.2 points.
PerformanceHCXY-0.52%IBB+29.51%
2025-06-09+0.00%2026-06-05
MetricHCXYIBB
Company
Hercules Capital, Inc.
iShares Nasdaq Biotechnology Index Fund
Price
$24.74-0.32%
$166.81-0.99%
Market cap
$4.53B
-
1M return
-0.32%
-2.00%
1Y return
-0.52%
+30.72%
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NYSE
NASDAQ
IPO
2018
n/a
News (4w)
0
0
Recent ratings
0
0
IBB

iShares Nasdaq Biotechnology Index Fund

The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Latest HCXY

Latest IBB